Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021242
Filing Date
2023-05-11
Accepted
2023-05-11 16:11:53
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grph-20230331.htm   iXBRL 10-Q 2109555
2 EX-31.1 grph-ex31_1.htm EX-31.1 20906
3 EX-31.2 grph-ex31_2.htm EX-31.2 21331
4 EX-32.1 grph-ex32_1.htm EX-32.1 12111
5 EX-32.2 grph-ex32_2.htm EX-32.2 11936
  Complete submission text file 0000950170-23-021242.txt   9191854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230331.xsd EX-101.SCH 68013
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230331_lab.xml EX-101.LAB 542621
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230331_pre.xml EX-101.PRE 404919
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grph-20230331_cal.xml EX-101.CAL 43120
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grph-20230331_def.xml EX-101.DEF 253685
65 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230331_htm.xml XML 1844985
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 23911136
SIC: 2836 Biological Products, (No Diagnostic Substances)